Replies to post #678609 on NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

Mr. Jerry Jasinowski retired from the Board of Directors of Northwest Biotherapeutics, Inc. on March 8, 2024, after more than a decade of service on the Board. Mr. Jasinowski, aged 85, retired due to health reasons and not due to any disagreement with the Company’s operations, policies or practices. The Company thanks Mr. Jasinowski for his many years of service on the Boar


https://finance.yahoo.com/sec-filing/NWBO/0001104659-24-034527_1072379?nn=1

[User-840664]

Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives

2022

'Vaccine-based therapies in glioblastoma ... to date no major successes with use of single-peptide, multipeptide, neoantigen-based, or dendritic cell-based vaccines in GBM leading to broad implementation.

Despite good tolerability and feasibility demonstrated across multiple studies, DC vaccine approaches did not demonstrate a survival benefit in a metanalysis.'